Skip to main content

Table 1 Patients included in the present analysis (SSA: somatostatin analog)

From: Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors

Patient

Source before SSA

Source after SSA

Treatment period (months)

1

Liver metastasis

Primary tumor

3

2

Liver metastasis

Primary tumor

13

3

Liver metastasis

Primary tumor

5

4

Primary tumor

Liver metastasis

2

5

Liver metastasis

Primary tumor

1

6

Liver metastasis

Primary tumor

1

7

Liver metastasis

Primary tumor

1

8

Liver metastasis

Primary tumor

1